Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cholangiocarcinoma: Epidemiology and risk factors
Shahid A. Khan, Simona Tavolari, Giovanni Brandi
Liver International (2019) Vol. 39, Iss. S1, pp. 19-31
Open Access | Times Cited: 613

Showing 1-25 of 613 citing articles:

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722
Cholangiocarcinoma
Paul J. Brindley, Melinda Bachini, Sumera I. Ilyas, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 503
Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Arndt Vogel, John Bridgewater, Julien Edeline, et al.
Annals of Oncology (2022) Vol. 34, Iss. 2, pp. 127-140
Open Access | Times Cited: 329
Systemic therapies for intrahepatic cholangiocarcinoma
Robin Kate Kelley, John Bridgewater, Gregory J. Gores, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 353-363
Open Access | Times Cited: 320
Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
Demetrios Moris, Manisha Palta, Charles Kim, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 73, Iss. 2, pp. 198-222
Open Access | Times Cited: 276
Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis
Paramita Dasgupta, Chloe Henshaw, Danny R. Youlden, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 208
Targeting FGFR inhibition in cholangiocarcinoma
Lipika Goyal, Sarinya Kongpetch, Valerie Crolley, et al.
Cancer Treatment Reviews (2021) Vol. 95, pp. 102170-102170
Open Access | Times Cited: 137
Updated Trends in Cancer in Japan: Incidence in 1985–2015 and Mortality in 1958–2018—A Sign of Decrease in Cancer Incidence
Kota Katanoda, Megumi Hori, Eiko Saito, et al.
Journal of Epidemiology (2021) Vol. 31, Iss. 7, pp. 426-450
Open Access | Times Cited: 125
Practical considerations in screening for genetic alterations in cholangiocarcinoma
Tanios Bekaii‐Saab, John Bridgewater, Nicola Normanno
Annals of Oncology (2021) Vol. 32, Iss. 9, pp. 1111-1126
Open Access | Times Cited: 108
Mitochondrial oxidative metabolism contributes to a cancer stem cell phenotype in cholangiocarcinoma
Chiara Raggi, Maria Letizia Taddei, Elena Sacco, et al.
Journal of Hepatology (2021) Vol. 74, Iss. 6, pp. 1373-1385
Open Access | Times Cited: 107
Current epidemiology of cholangiocarcinoma in Western countries
Mathew Vithayathil, Shahid A. Khan
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1690-1698
Closed Access | Times Cited: 106
Novel microenvironment-based classification of intrahepatic cholangiocarcinoma with therapeutic implications
Miguel A. Martín-Serrano, Benjamin Kepecs, Miguel Torres‐Martín, et al.
Gut (2022) Vol. 72, Iss. 4, pp. 736-748
Open Access | Times Cited: 90
Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects
Qin Ru, Yusheng Li, Lin Chen, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 56
Liver diseases: epidemiology, causes, trends and predictions
Can Gan, Yuan Yuan, Haiyuan Shen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Digestive cancers: mechanisms, therapeutics and management
Tianzuo Zhan, Johannes Betge, Nadine Schulte, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 2
Pathogenesis of Cholangiocarcinoma
Pedro M. Rodrigues, Paula Olaizola, Nuno A. Paiva, et al.
Annual Review of Pathology Mechanisms of Disease (2020) Vol. 16, Iss. 1, pp. 433-463
Open Access | Times Cited: 108
Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives
Alessandro Rizzo, Angela Dalia Ricci, Simona Tavolari, et al.
Cancer Genomics & Proteomics (2020) Vol. 17, Iss. 5, pp. 441-452
Open Access | Times Cited: 92
Evolution of the Experimental Models of Cholangiocarcinoma
Annamaria Massa, Chiara Varamo, Francesca Vita, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2308-2308
Open Access | Times Cited: 89
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma
Yuhua Huang, Chris Zhiyi Zhang, Qunsheng Huang, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 4, pp. 838-849
Open Access | Times Cited: 82
Nerve fibers in the tumor microenvironment in neurotropic cancer—pancreatic cancer and cholangiocarcinoma
Xiuxiang Tan, Shivan Sivakumar, Jan Bednarsch, et al.
Oncogene (2020) Vol. 40, Iss. 5, pp. 899-908
Open Access | Times Cited: 81
Anti-EGFR Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-analysis
Alessandro Rizzo, Giorgio Frega, Angela Dalia Ricci, et al.
In Vivo (2020) Vol. 34, Iss. 2, pp. 479-488
Open Access | Times Cited: 78
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
Alessandro Rizzo, Angela Dalia Ricci, Nastassja Tober, et al.
Anticancer Research (2020) Vol. 40, Iss. 6, pp. 3013-3030
Open Access | Times Cited: 71
Pathogens and Carcinogenesis: A Review
Muhammad Hatta, Ezanee Azlina Mohamad Hanif, Siok‐Fong Chin, et al.
Biology (2021) Vol. 10, Iss. 6, pp. 533-533
Open Access | Times Cited: 66
Cell of origin in biliary tract cancers and clinical implications
Agrin Moeini, Philipp K. Haber, Daniela Sia
JHEP Reports (2021) Vol. 3, Iss. 2, pp. 100226-100226
Open Access | Times Cited: 59
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation
Anya Burton, Daniela Tataru, R. Driver, et al.
JHEP Reports (2021) Vol. 3, Iss. 2, pp. 100232-100232
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top